Indian Journal of Human Genetics
Home Current Issue Archives Guidelines Subscriptions e-Alerts Login 
Users online: 20
Print this page  Email this page Small font sizeDefault font sizeIncrease font size
Year : 2014  |  Volume : 20  |  Issue : 2  |  Page : 101-119

Guidelines for screening, diagnosis and management of hemoglobinopathies

1 National Institute of Immunohaematology, Indian Council of Medical Research, K.E.M. Hospital, Parel, Mumbai, India
2 Department of Pediatrics and Chief, Division of Hematology-Oncology, LTMG Hospital, Mumbai, India
3 Department of Hematology, Sun Flag Hospital, New Delhi, India
4 Department of Medical Genetics, Sir Ganga Ram Hospital, New Delhi, India
5 Department of Hematology, Former Head, University College of Medical Sciences, New Delhi, India
6 Department of Hematology, AIIMS, New Delhi, India
7 Department of Pediatrics, Government Medical Hospital, Akola, Maharashtra, India
8 Department of Transfusion Medicine, PGIMER, Chandigarh, India
9 Department of Hematology, PGIMER, Chandigarh, India
10 Department of Hematology, Apollo Hospital, Bhubhaneshwar, India
11 Department of Transfusion Medicine, SGPGI, Lucknow, India
12 Department of Genetics, SGPGI, Lucknow, India
13 Department of Hematology, NRS Medical College, Kolkata, India
14 Department of Hematology, St. John's Medical College, Bangalore, Karnataka, India

Correspondence Address:
Kanjaksha Ghosh
Director, National Institute of Immunohaematology, 13th Floor, NMS Bldg, KEM Hospital Campus, Parel, Mumbai - 400 012
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0971-6866.142841

Rights and Permissions

The β-thalassemias and sickle cell disorders are a major health burden in India. Diagnosis and management of these disorders both in adults and in newborns using appropriate approaches and uniform technology are important in different regions of a vast and diverse country as India. In view of a National Thalassemia Control Program to be launched soon, a need was felt for guidelines on whom to screen, cost-effective technologies that are to be used as well as for establishing prenatal diagnosis programs in regional centers. Newborn screening for sickle cell disorders is in its infancy in India and uniform approaches need to be followed. Also, included are guidelines for monitoring and managing patients who are now growing older and need comprehensive care as well as management of complications of the disease.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded408    
    Comments [Add]    

Recommend this journal